Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
Jeremy MacMahon, Yi-Hua Tsai, and Pamela Lein from the Department of Molecular Biosciences, UC Davis School of Veterinary Medicine, explore how shellfish poisoning is affecting human and animal health.
Affecting 10 million pregnancies worldwide, this piece explores the ways preeclampsia testing is utilised to save lives, the hidden dangers of the condition and the demographics that are at most risk.
Mary Hardcastle at RapidAI looks at the advancements in health tech, explaining what hospitals need to do to implement Artificial Intelligence in the ER.
Dr Helen M Rowe at the Centre for Immunobiology at the Queen Mary University of London looks towards unlocking dark matter for the potential to boost immune responses in humans.
Sabine Mai and Aline Rangel-Pozzo, at the CancerCare Manitoba Research Institute and The University of Manitoba, Winnipeg, Canada, discuss genomic instability in relation to 3D spatial organization of telomeres.
